Literature DB >> 16086438

Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease.

I Szanto1, L Rubbia-Brandt, P Kiss, K Steger, B Banfi, E Kovari, F Herrmann, A Hadengue, K-H Krause.   

Abstract

Reactive oxygen species (ROS) are at the centre of many physiological and pathological processes. NOX1, a ROS-producing NADPH oxidase, is highly expressed in the colon but its function in colonic physiology or pathology is still poorly understood. It has been suggested to play a role in host defence, but also in cell growth and possibly malignant transformation. In this study we characterized NOX1 expression in human colon samples derived from healthy control subjects and patients with colon cancer or inflammatory bowel disease (IBD). NOX1 mRNA expression was assessed by dot-blot hybridization, real-time PCR and in situ hybridization, using samples derived from surgical specimens from patients undergoing colon resection. In normal tissues, NOX1 expression was low in the ileum, intermediate in the right colon, and high in the left colon (p = 0.0056 right vs. left colon). NOX1 mRNA levels were not influenced by factors linked to colon tumourigenesis, such as age or sex. Moreover, there was no statistical difference in NOX1 expression between samples derived from adenomas, well differentiated or poorly differentiated colon adenocarcinomas. At a cellular level, NOX1 was highly expressed in colon epithelial cells, both within the crypts and on the luminal surface. In addition, a population of lymphocytes, particularly in the appendix, showed NOX1 expression. Lymphocytes in lesions of Crohn's disease and ulcerative colitis were also strongly positive for NOX1. In conclusion, NOX1 is an enzyme that is constitutively expressed in colon epithelium and is not associated with tumourigenesis. Its distribution in crypts and on the luminal surface, as well as its left-to-right gradient in the colon, suggests a role in host defence function. In addition to the known epithelial localization, we define lymphocytes as a novel site of NOX1 expression, where it may potentially be involved in the pathogenesis of inflammatory bowel diseases. Copyright (c) 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16086438     DOI: 10.1002/path.1824

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  82 in total

Review 1.  ROS in gastrointestinal inflammation: Rescue Or Sabotage?

Authors:  G Aviello; U G Knaus
Journal:  Br J Pharmacol       Date:  2016-03-03       Impact factor: 8.739

Review 2.  Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.

Authors:  Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Circ Res       Date:  2012-05-11       Impact factor: 17.367

Review 3.  Gene-Diet Interactions on Colorectal Cancer Risk.

Authors:  Li-Shu Wang; Chieh-Ti Kuo; Yi-Wen Huang; Gary D Stoner; John F Lechner
Journal:  Curr Nutr Rep       Date:  2012-07-10

Review 4.  Antimicrobial actions of dual oxidases and lactoperoxidase.

Authors:  Demba Sarr; Eszter Tóth; Aaron Gingerich; Balázs Rada
Journal:  J Microbiol       Date:  2018-06-01       Impact factor: 3.422

5.  Aquaporin-3 mediates hydrogen peroxide-dependent responses to environmental stress in colonic epithelia.

Authors:  Jay R Thiagarajah; Jeffrey Chang; Jeremy A Goettel; Alan S Verkman; Wayne I Lencer
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-03       Impact factor: 11.205

Review 6.  Nox enzymes in immune cells.

Authors:  William M Nauseef
Journal:  Semin Immunopathol       Date:  2008-05-01       Impact factor: 9.623

Review 7.  Therapeutic potential of NADPH oxidase 1/4 inhibitors.

Authors:  G Teixeira; C Szyndralewiez; S Molango; S Carnesecchi; F Heitz; P Wiesel; J M Wood
Journal:  Br J Pharmacol       Date:  2016-07-14       Impact factor: 8.739

8.  The Gdac1 locus modifies spontaneous and Salmonella-induced colitis in mice deficient in either Gpx2 or Gpx1 gene.

Authors:  R Steven Esworthy; Byung-Wook Kim; Yufeng Wang; Qiang Gao; James H Doroshow; Thomas L Leto; Fong-Fong Chu
Journal:  Free Radic Biol Med       Date:  2013-10-01       Impact factor: 7.376

Review 9.  NADPH oxidases in lung health and disease.

Authors:  Karen Bernard; Louise Hecker; Tracy R Luckhardt; Guangjie Cheng; Victor J Thannickal
Journal:  Antioxid Redox Signal       Date:  2014-01-03       Impact factor: 8.401

10.  Gadolinium chloride attenuates acetic acid-evoked colitis in mice by reducing neutrophil infiltration and pro-oxidative enzyme activity.

Authors:  Meriem Ferrat; Hichem Moulahoum; Belkacem Mohamed Amine Boumaza; Souad Mouzaoui; Axel Périanin; Bahia Djerdjouri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-11-27       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.